Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H UMEZAWA

Showing results (1-10 of 314) with videos related to

Pageof 32
Sort By:
Reviews of Infectious Diseases|May 1, 1984
Studies on low-molecular-weight immunomodifiers produced by microorganisms: results of ten years' effortH Umezawa
The Japanese Journal of Antibiotics|December 1, 1979
Studies on aminoglycoside antibiotics: enzymic mechanism of resistance and geneticsH Umezawa
Antibiotics and Chemotherapy|January 1, 1978
Small molecular microbial products enhancing immune responseH Umezawa
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1982
Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganismsH Umezawa
La Nouvelle Presse Medicale|November 18, 1982
[Discovery of dibekacin and its chemical aspects]H Umezawa
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Screening of small molecular microbial products modulating immune responses and bestatinH Umezawa
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
New microbial secondary metabolites under preclinical development for cancer treatmentH Umezawa
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|July 1, 1977
Microbial secondary metabolites with potential use in cancer treatment. (Plasmid involvement in biosynthesis and compoundsH Umezawa
Antibiotics and Chemotherapy|January 1, 1978
Recent advances in antitumor antibioticsH Umezawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1983
[Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators]H Umezawa
Pageof 32

Showing results (1-10 of 314) with videos related to

Sort By:
Pageof 32
Reviews of Infectious Diseases|May 1, 1984
Studies on low-molecular-weight immunomodifiers produced by microorganisms: results of ten years' effortH Umezawa
The Japanese Journal of Antibiotics|December 1, 1979
Studies on aminoglycoside antibiotics: enzymic mechanism of resistance and geneticsH Umezawa
Antibiotics and Chemotherapy|January 1, 1978
Small molecular microbial products enhancing immune responseH Umezawa
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1982
Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part II - Small molecular weight immunomodulators produced by microorganismsH Umezawa
La Nouvelle Presse Medicale|November 18, 1982
[Discovery of dibekacin and its chemical aspects]H Umezawa
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
Screening of small molecular microbial products modulating immune responses and bestatinH Umezawa
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1978
New microbial secondary metabolites under preclinical development for cancer treatmentH Umezawa
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|July 1, 1977
Microbial secondary metabolites with potential use in cancer treatment. (Plasmid involvement in biosynthesis and compoundsH Umezawa
Antibiotics and Chemotherapy|January 1, 1978
Recent advances in antitumor antibioticsH Umezawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1983
[Secondary microbial metabolites with potentials for antineoplastic actions: antineoplastic antibiotics and immunopotentiators]H Umezawa
Pageof 32